Zachary S Morris

19PUBLICATIONS
128CO-AUTHORS
Radiation therapyMolecular targetsInnate immunityEpigenetics (incl. genome methylation and epigenomics)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Jul 08, 2026
In situ vaccination, low-dose targeted radionuclide therapy, and immune checkpoint inhibition eradicate poorly immunogenic metastatic tumors in murine cancer models.

|May 01, 2026
Preclinical Evaluation of Radium-223 and Immune Checkpoint Inhibitors Using an Immune-Competent Model of Prostate Cancer Bone Metastases.

|Apr 23, 2026
Radionuclide-Dependent Stimulation of Antitumor Immunity in GD2-Targeted Radiopharmaceutical Therapy Combined with Immune Checkpoint Inhibitors.

|Mar 05, 2026
Matching Patients With Cell Surface-Targeted Clinical Trials Using Large Language Models.

S Carson Callahan, Matthew R Chrostek, Nicholas Rydzewski

|Jan 26, 2026
Priming versus propagating: distinct immune effects of alpha- versus beta-particle emitting radiopharmaceuticals when combined with immune checkpoint inhibition in mice.

Caroline P Kerr, Won Jong Jin, Peng Liu

|Dec 05, 2025
Combined innate immune cell therapy, tumor-specific antibody, and radiation prompt antitumor response in pancreatic cancer models.

Md Mahfuzur Rahman, Andrea Pennati, Tavus Atajanova

Pageof 4

Frequent Collaborators

8 joint publications

Wonjong Jin

6 joint publications

Paul M Sondel

5 joint publications

Ohyun Kwon

5 joint publications

Paul A Clark